DrugPatentWatch Database Preview
AXUMIN Drug Profile
Which patents cover Axumin, and what generic alternatives are available?
Axumin is a drug marketed by Blue Earth and is included in one NDA. There are three patents protecting this drug.
This drug has thirty-six patent family members in fifteen countries.
The generic ingredient in AXUMIN is fluciclovine f-18. One supplier is listed for this compound. Additional details are available on the fluciclovine f-18 profile page.
Summary for AXUMIN
| International Patents: | 36 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 6 |
| Clinical Trials: | 4 |
| Patent Applications: | 16 |
| DailyMed Link: | AXUMIN at DailyMed |
Generic Entry Opportunity Date for AXUMIN
Generic Entry Date for AXUMIN*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY NDA:
Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for AXUMIN
| Drug Class | Radioactive Diagnostic Agent |
| Mechanism of Action | Positron Emitting Activity |
Synonyms for AXUMIN
| (18F)FACBC |
| (18F)Fluciclovine |
| (18F)Ge-148 |
| (1R,3R)-1-Amino-3(18f)fluorocyclobutane-1-carboxylic acid |
| [18F]-FACBC |
| [18F]FACBC |
| [18F]Fluciclovine |
| 1-amino-3-fluoranylcyclobutane-1-carboxylic acid |
| 18F fluciclovine |
| 18F-Ge-148 |
| 222727-39-1 |
| 38R1Q0L1ZE |
| AC1L9P1E |
| AKOS030238192 |
| anti-(18f)FABC |
| Anti-[18F]FACBC |
| anti-1-Amino-3-(18f)fluorocyclobutane-1-carboxylic acid |
| Anti-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid |
| Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic-acid |
| Anti-1-amino-3-F-18-fluorocyclobutane-1-carboxylic-acid |
| Anti-1-amino-3-fluorine-18-fluorocyclobutane-1-carboxylic acid |
| Anti-18-F-FACBC |
| Anti-18F-FABC |
| Anti-3-18F-FACBC |
| Anti-F-18-fluorocyclobutane-carboxylic-acid |
| AxuminCN FACBCCN Fluciclovine (18F)CN GE 148CN NMK 36 |
| CHEBI:134703 |
| CHEMBL254468 |
| CHEMBL447701 |
| D03QIP |
| D10860 |
| DB13146 |
| FACBC |
| FACBC F-18 |
| Fluciclovine |
| Fluciclovine ((sup 18)F) |
| Fluciclovine ((sup 18)F) [INN] |
| Fluciclovine (18F) |
| Fluciclovine (18F) (INN) |
| Fluciclovine (18F) [INN] |
| Fluciclovine F 18 |
| Fluciclovine F-18 |
| Fluciclovine F18 [USAN] |
| Fluciclovine-F-18 |
| GE-148 |
| Ge-148 (18F) |
| Ge-148 F-18 |
| Ge-148-18F |
| Ge-148-F-18 |
| MOLI001120 |
| NMK36 |
| SCHEMBL10017245 |
| SCHEMBL11939897 |
| SCHEMBL11939900 |
| syn-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid |
| syn-3-[18F]FACBC |
| Trans-1-amino-3-18F-fluorocyclobutanecarboxylic-acid |
| UNII-38R1Q0L1ZE |
US Patents and Regulatory Information for AXUMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for AXUMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for AXUMIN
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2013177468 | ➤ Try a Free Trial |
| Japan | 5684333 | ➤ Try a Free Trial |
| New Zealand | 568179 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
